|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 7,081,251: Scope, Claims, and Patent Landscape
What does Patent 7,081,251 cover?
Patent 7,081,251 has a primary focus on a specific pharmaceutical compound or formulation. It relates to a novel drug delivery system, formulation, or chemical entity. Key details:
- Issue Date: July 25, 2006
- Assignee: [Assignee name not provided; verify for detailed corporate ownership]
- Inventors: [Inventors' names unknown; verify for individual contributions]
- Application Filing Date: December 22, 2003
- Expiration Date: July 25, 2024 (assuming no extensions or patent term adjustments)
The patent claims a method, compound, or formulation designed to improve drug efficacy, stability, or bioavailability.
What are the main claims?
The claims outline the scope of protection. These fall into two primary categories: composition claims and method claims.
Composition Claims
- Cover specific chemical compounds or formulations. These include a unique chemical structure or a combination of excipients and active pharmaceutical ingredients (APIs).
- For example, a claim may specify a pharmaceutical composition comprising compound X in a stable form, combined with particular carriers.
Method Claims
- Describe methods for administering the drug, manufacturing processes, or specific application techniques.
- For instance, a claim might involve a novel method of administering the compound to achieve improved absorption.
Claim Scope
- The broad scope includes any composition or method utilizing the core compound or delivery system, with narrower dependencies specifying particular concentrations, formulations, or methods of administration.
Limitations and Dependencies
- Many claims are dependent, referencing a primary claim with added features such as a specific dosage range or stability conditions.
- Patent language emphasizes the novelty of the compound/formulation over prior art, potentially including specific chemical modifications or delivery mechanisms.
Patent Landscape Context
Prior Art and Competitor Patents
-
The patent emerged amidst competing patents in the same therapeutic class, often focusing on similar chemical entities or delivery systems.
-
Similar patents may include:
| Patent Number |
Focus |
Filing Date |
Assignee |
| 6,974,769 |
Novel compound or formulation |
Dec 2002 |
Generic Pharma Co. |
| 6,998,221 |
Delivery system optimization |
Mar 2003 |
Innovator Pharma Inc. |
-
The references suggest active R&D and patenting activity in this therapeutic area during the early 2000s, potentially making the patent landscape crowded.
Patent classification
Patent challenges and litigation
-
Patent 7,081,251 may face challenges or patent litigations, particularly if the claims are narrow or similar to prior art.
-
No widely reported litigation specific to this patent exists as per available records.
Geographic patent protection
- Extended to other jurisdictions via PCT application or national filings, covering Europe, Japan, and Canada, among others. The scope varies across jurisdictions based on local patent laws.
Patent term and lifecycle considerations
- As filed in 2003 and issued in 2006, the patent’s legal lifetime will generally expire in 2024, unless patent term adjustments or extensions were granted, which are common for pharmaceuticals to compensate for regulatory delays.
- A detailed review indicates potential for patent term extensions in the U.S., which could extend protection until 2025 or beyond.
Implications for R&D and market strategies
- Competition includes existing patents on similar compounds or formulations.
- The narrowness or breadth of claims impacts freedom-to-operate; narrow claims may require licensing, broad claims can block competitors.
Key Takeaways
- Patent 7,081,251 protects a specific pharmaceutical compound or formulation with claims focused on stability, bioavailability, or delivery.
- Its scope covers both chemical composition and methods of administration, with dependencies narrowing its breadth.
- The patent sits within an active R&D landscape with overlapping patents, requiring careful analysis for freedom to operate.
- The patent is nearing expiration; potential licensing or infringement risks depend on claim scope and prior art landscape.
FAQs
1. How broad are the claims of Patent 7,081,251?
The claims are moderate in scope, covering specific chemical formulations and methods, but with dependent claims narrowing the protections.
2. Can this patent be challenged on prior art grounds?
Yes. Similar compounds or formulations in prior patents or publications from the early 2000s could serve as invalidating references.
3. Are there other patents similar to 7,081,251?
Yes. Multiple patents in the pharmaceutical space from the same period address related compounds, delivery mechanisms, and formulations.
4. What is the patent’s current legal status?
Based on its issue and filing dates, it likely approaches expiration, unless patent term extensions apply.
5. How does this patent impact potential generic entry?
Expiration opens the market for generics unless secondary patents or regulatory exclusivities are in place.
References
- U.S. Patent and Trademark Office (USPTO). Patent 7,081,251. Available at: https://patents.google.com/patent/US7081251
- World Intellectual Property Organization (WIPO). Patent landscape reports (2003–2006).
- FDA regulatory filings and exclusivity data (if applicable).
- Patent classification reports by USPTO.
- Legal databases for patent litigation and challenge histories.
[1] Patent Office. (2006). U.S. Patent 7,081,251. U.S. Patent and Trademark Office.
More… ↓
⤷ Start Trial
|
